Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 607-997-7 | CAS number: 26776-30-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The test item is of low oral and inhalative acute toxicity with an oral LD50 (rat) of > 1800 mg/kg bw (NOTOX, 2002 and Bayer; 2008) and an inhalative LC50 (rat, aerosol, 4 hrs) of > 3069 mg/m3 (BHC, 2012).
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2002-11-12 to 2002-11-28
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- (1996)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Version / remarks:
- (1996)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Version / remarks:
- (1996)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ORGANISMS:
- Source: WISTAR strain Crl: (EI) BR , Charles River Deutschland, Sulzfeld
- young adult animals
- Fasting period before study: maximum 20 hours
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 5 days
- Temperature (°C): 21 °C +/- 3° C
- Humidity (%): 30 % - 70 %
- Air changes (per hr): 15 times
- Illumination: 12 hours artifical fluorescent light and 12 hours dark - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- ADMINISTRATION:
- Frequency: single dosage on day 1
- Dose: 2000 mg/kg/bw (1.83 ml/kg), undiluted
- Dose volume was calculated as dose level: density - Doses:
- 2000 mg/kg, correlating to 1800 mg/kg (based on active ingredient of test substance)
- No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: periodic intervals on the dayof dosing (day 1) and once daily thereafter, until day 15
- Body weight: days 1 (pre-administration) 8 and 15
- Necropsy: All survived animals were necropsied at the end of the observation period - Statistics:
- not required
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 1 800 mg/kg bw
- Based on:
- act. ingr.
- Remarks on result:
- other: 90 % substance in solvent
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortalitiy occurred
- Clinical signs:
- other: Hunched posture, lethargy, rales, red or brown staining of the skin, salivation, chromodacryorrhoea and ptosis were noted among the animals between days 1 and 4. Alopecia was observed in 3 females between days 11 and 15 and in one male between days 5 and
- Gross pathology:
- No abnormalities were found at macroscopic post mortem examination of the animals.
- Other findings:
- no other findings
- Interpretation of results:
- other: as test item a 90 % solution in solvent naphtha was used; the induced effects might be interpreted as solvent driven
- Conclusions:
- The oral LD50 value of 2H-Azepin-2-one, hexahydro-, polymer with 1,6 diisocyanatohexane in female and male Wistar rats was established to exceed 2000 mg/kg bw for the test substance (> 1800 mg/kg based on active ingredient). No mortalities were observed. Therefore, under the conditions of this study the acute toxicity of 2H-Azepin-2-one, hexahydro-, polymer with 1,6 diisocyanatohexane after oral exposure in rats is low.
- Executive summary:
The study for assessment of acute oral toxicity with 2H-Azepin-2-one, hexahydro-, polymer with 1,6 diisocyanatohexane in rats was carried out according to OECD Guideline 423. The test item was administered by oral gavage to three Wistar rats of each sex at 2000 mg/kg bw (1800 mg/kg based on active ingredient). Animals were subjected to daily observations and weekly determination of body weight. Macroscopic examination was performed after terminal sacrifice (day 15). No mortality occurred. Hunched posture, lethargy, rales, red or brown staining of the skin, salivation, chromodacryorrhoea and ptosis were noted among the animals between days 1 and 4. Alopecia was observed in 3 females between days 11 and 15 and in one male between days 5 and 15. As test item a 90% solution in solvent naphta was used. The induced effects could be interpreted as solvent driven. The body weight gain shown by the animals over the study period was considered to be normal. No abnormalities were found at macroscopic post mortem examination of the animals.
Therefore the oral LD50 value of 2H-Azepin-2-one, hexahydro-, polymer with 1,6 diisocyanatohexane in Wistar rats was established to exceed 2000 mg/kg bw (> 1800 mg/kg based on active ingredient).
Reference
no other information
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 1 800 mg/kg bw
- Quality of whole database:
- The study is valid without restriction (Klimisch score 1).
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2012-06-27 to 2012-07-24
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Version / remarks:
- 2009
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.2 (Acute Toxicity (Inhalation))
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ORGANISMS:
- Strain: WISTAR HsdCpd:WU
- Source: Harlan-Nederland
- Age: young adult
- Weight at study initiation: males: 170.0 - 200.0 g, females: 166.0 - 183.0 g
- Number of animals: 13 males and 13 females
- Housing: singly in Makrolon Type III cages
- Diet: ad libitum, ssniff R/M-H
- Water: ad libitum, tap water
- Acclimatisation period: at least 5 days, during this period, rats were also acclimatized to the restraining tubes
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22°C +/- 3 °C
- Humidity (%): 40 - 60 %
- Photoperiod (hrs dark / hrs light): 12 hours darkness, 12 hours artifical light
- Ventilation: approx. 10 air changes per hour - Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- other: ethyl acetate and dry compressed air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Type of exposure: nose-only, using a dynamic inhalation apparatus, comparable with a directed-flow exposure
- Method of holding animals in test chamber: separately in Plexiglas exposure restrainers
- Source of air: dry compressed filtered air
- Method of conditioning air: manometer and air-flow meter (TSI Mass Flow-meter 4040), flow rates were monitored continuously by flow meters
and if necessary readjusted
- Type or preparation of particles: Portions of the solid test article were scrapped-off from the resin and were dissolved in ethyl acetate at a targeted concentration of 20 %(w/v). Stability was verified over 7 days. Nebulization of the resin was attempted up to 80°C (decomposition temperature
100°C). Despite these effects, the test article remained in a physical state of high viscosity with glue-like properties. The last resource was to
aerosolize the test article in ethyl acetate at relative low concentration (20%) and low nozzle accordingly.
Under dynamic conditions the test substance is atomized into the baffle (pre-separator) of the inhalation chamber. For atomization a binary
Schlick-type nozzle and conditioned compressed air (15 Llmin) was used. The representative dispersion pressure was in the range of 600 kPa. The nozzle was maintained at 10°C by a water jacket connected to a digitally controlled water bath. The test article was injected into the nozzle system
using a digitally controlled pump (Harvard PHD 2000 infusion pump). In the control group conditioned dry air only was used. The same
aerosolization principles were used in the vehicle and test article groups. The atomization temperature and concentration of the test article in the
vehicle was optimized to attain stable and highly respirable aerosol concentrations at the expense of a high concentration of vehicle.
- Analysis of the aerosol concentration: The actual aerosol concentration in the inhalation chamber was measured gravimetrically with an air sample
filter (Minisart SM 17598 0.45 µm) and pump (Vacuubrand, MZ 2C ) controlled by a rotameter. Dust samples were taken once every hour during the exposure
- Method of particle size distribution: The particle-size distribution was analyzed using a BERNER critical orifice cascade impactor. Each impactor
stage was covered by an aluminum foil and an additional glass fiber filter to prevent liquid run-off from the filter. Gravimetric analyses of filters
used a digital balance. Prior to gravimetric analysis the filter was dried for 30 min @70°C. Due to the glue-like properties, no additional coating
agent was used to minimize bouncing and re-entrainment of aerosol. The samples for the analysis of the particle-size distribution were taken in the
vicinity of the breathing zone. During each exposure two samples were taken, which was the maximum feasible due to the analytical samples taken.
- Temperature, humidity: T: 21.8 - 22.5 °C, H: = 5 %, Temperature and humidity data are integrated for 30-seconds and displayed accordingly
TEST ATMOSPHERE
- Concentrations: 3069 mg/m³
Air flow entrance (L/min): 15
Air flow exit (L/min): 12.8
Air change (changes per hour): 237
- Analytical method used: The nominal concentration was calculated from the ratio of the quantity of the atomized liquid and the total throughput of air through the inhalation chamber.The test-substance concentration was determined by gravimetric analysis (filter: glass-fiber filter, Sartorius,
Gottingen, Germany; digital balance). This method was used to define the actual concentration.
- Samples taken from breathing zone: Chamber samples were taken in the vicinity of the breathing zone
- MMAD (Mass median aerodynamic diameter): 2.7 µm
- GSD (Geometric st. dev.): 2.6
VEHICLE
- Composition of vehicle: etyl acetate purum, an atomization without the carrier ethyl acetate at an already mildly toxic concentration
(3069 mg/m3 ) was technically not feasible
CONTROL ANIMALS
- 5m/5f: conditioned air
- 5m/5f: vehicle ethyl acetate - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- The nominal concentration was calculated from the ratio of the quantity of the atomized liquid and the total throughput of air through the inhalation chamber.
- Duration of exposure:
- 4 h
- Concentrations:
- Gravimetric concentration of 3069 mg test item/m3
The respirability of the aerosol was adequate to achieve the objective of study, i.e. the average mass median aerodynamic diameter (MMAD) was
2.7 µm, the average geometric standard deviation (GSD) was 2.6. - No. of animals per sex per dose:
- 3
- Control animals:
- yes
- Details on study design:
- EXAMINATIONS:
- Post dose observation period: 14 days
- body weights: before exposure, on days 1, 3, 7 and 14 after treatment
- mortality: time of death is recorded as precisely as possible
- clinical signs: several times on the day of exposure and at least once daily thereafter, no specific assessment was performed during exposure while animals were restrained, only if unequivocal signs occurred e.g. spasms, abnormal movements, and severe respiratory signs.
Following exposure, observations are made and recorded systematically; individual records are maintained for each animal. Cage-side
observations included, but were not limited to, changes in the skin and fur, eyes, mucus membranes, respiratory, circulatory, autonomic and
central nervous system, and somatomotor activity and behavior pattern. Particular attention was directed to observation of tremors, convulsions,
salivation, diarrhea, lethargy, somnolence and prostration.
The following reflexes were tested: visual placing response and grip strength on wire mesh, abdominal muscle tone, corneal and pupillary reflexes, pinnal reflex, righting reflex, tail-pinch response, startle reflex with respect to behavioral changes stimulated by sounds (finger snapping) and
touch (back).
- rectal temperatures: were measured shortly after cessation of exposure (approximately within 1/2 hour after the end of exposure) using a digital thermometer with a rectal probe for rats.
- Necropsy: All rats, irrespective of the day of death, were given a gross-pathological examination, with particular reference to changes related to
the respiratory tract. - Statistics:
- Data of body weights and rectal temperature measurements are statistically evaluated using the ANOVA procedure.
- Preliminary study:
- The maximum technically attainable concentration is 3069 mg test item/m3.
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 3 069 mg/m³ air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Remarks on result:
- other: maximum technically achievable concentration
- Mortality:
- No animal died prematurely.
- Clinical signs:
- other: Group 1-males & females: No specific signs observed. Group 2-males: Bradypnea, labored breathing patterns, piloerection. Group 2-females: Bradypnea labored breathing patterns, piloerection, motility reduced, atony Group 3-males: Bradypnea, labored breathi
- Body weight:
- Comparisons between the vehicle control and the test article exposure group did not reveal significant differences of body weight gains.
- Gross pathology:
- There were no observable findings at the end of the study. The macroscopic findings of extrapulmonary organs were essentially indistinguishable
amongst the groups. - Other findings:
- A battery of reflex measurements was made on the first post-exposure day, differences between groups 1 to 3 were not observed.
- Conclusions:
- In summary, the aerosolized test substance 2H-Azepin-2-one, hexahydro-, polymer with 1,6 diisocyanatohexane proved to have a low acute inhalation toxicity to rats. Due to the similarity of the vehicle and test article group, it seems that the glue-like resin aerosol may have acted as carrier for the liquid vehicle which aggravated the response observed. An atomization without the carrier ethyl acetate at an already mildly toxic concentration (3069 mg/m3) was
technically not feasible.
LC50inhalation (liquid aerosol, 4 h): LC50 males & females: >3069 mg/m3
NO(A)EL: males & females: <3069 mg/m3 air - Executive summary:
The aim of the present experiment was to obtain information on the acute toxicity and LC50, following a single 4-hour inhalation exposure in an acute inhalation study in WISTAR rats.
A study on the acute inhalation toxicity of 2H-Azepin-2-one, hexahydro-, polymer with 1,6 diisocyanatohexane on rats has been conducted in accordance with OECD TG 403 (2009). Test procedures were adapted so as to comply also with the EU Directive 92/69/EEC, and especially OECD GD 39 (2009). One group of rats was nose-only exposed to a concentration of 3069 mg/m3 (maximum technically achievable concentration). The aerosol was generated using the vehicle ethyl acetate. Test article exposed rats were compared to a historical air control group and a concurrent vehicle control group. The results can be summarized as follows:
LC50inhalation (liquid aerosol, 4 h): LC50 males & females: >3069 mg/m3 air
NO(A)EL: males & females: < 3069 mg/m3 air
Mortality did not occur up to the maximum technically attainable concentration of 3069 mg/m3. The clinical signs observed in the vehicle control (bradypnea, labored breathing patterns, piloerection, motility reduced, atony) and in the test article group (bradypnea, labored breathing patterns, piloerection, motility reduced, atony, gait high-legged, muzzle area: red encrustations, hair-coat: clotted and depilated areas) were somewhat similar but differed markedly in their duration (up to the first postexposure day in the vehicle group and first postexposure week in the test article group. The changes in body weights and rectal temperature (hypothermia) were essentially indistinguishable between these groups. The hair-coat with clotted and depilated areas was clearly related to the glue-like physical properties of the test article.
The respirability of the aerosol was adequate to achieve the objective of study, i.e. the average mass median aerodynamic diameter (MMAD) was 2.7 µm, the average geometric standard deviation (GSD) was 2.6.
In summary, the aerosolized test substance proved to have a low acute inhalation toxicity to rats. Due to the similarity of the vehicle and test article group, it seems that the glue-like resin aerosol may have acted as carrier for the liquid vehicle which aggravated the response observed. An atomization without the carrier ethyl acetate at an already mildly toxic concentration (3069 mg/m3) was technically not feasible.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 3 069 mg/m³ air
- Quality of whole database:
- The study is valid without restriction (Klimisch score 1).
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Data waiving:
- other justification
- Justification for data waiving:
- other:
Reference
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
2H-Azepin-2-one, hexahydro-, polymer with 1,6 diisocyanatohexane was of low oral acute toxicity when tested up to the limit dose of 2000 mg/kg bw. Since commercial products with 90% and 72% active ingredient in solvent were tested the oral LD50 (rat) was actually > 1800 mg/kg bw and 1440 mg/kg bw, respectively (NOTOX, 2002 and Bayer, 2008). For acute inhalation toxicity a LC50 (rat, aerosol, 4 hrs) of > 3069 mg/m3 (maximum technically achievable concentration; BHC, 2012) was found.
Justification for selection of acute toxicity – oral endpoint
The study with the highest test concentration (90% test item in
solvent) is selected.
Justification for selection of acute toxicity – inhalation endpoint
Only one study available.
Justification for selection of acute toxicity – dermal endpoint
According to REACH Annex VIII (Column 2 of section 8.5.3) acute
dermal study is not needed, because inhalation is considered to be the
relevant route of exposure during production / use of the substance.
Justification for classification or non-classification
Based on the available studies no classification on acute oral toxicity according to Regulation (EC) No 1272/2008, Annex I is concluded. Although the maximum oral dose of the substance tested was 1800 mg/kg (commercial product with 90 % content of the active ingredient) and thus below the limit for non-classification of 2000 mg/kg, it can be assumed that the LD50 for 2H-Azepin-2-one, hexahydro-, polymer with 1,6 diisocyanatohexane is higher than 2000 mg/kg bw, as only slightly effects were observed which could be interpreted as solvent driven. Furthermore, based on the available study also no classification on acute inhalatin toxicity according to Regulation (EC) No 1272/2008, Annex I is concluded as the maximum technically achievable concentration of 3069 mg/m3 was tested and no test substance related effects were observed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.